AI Assisted Legacy Program for Serious Illness Patients
AI Assisted Personalized Legacy Program
Supportive Care Study
Summary
Study start date: August 11, 2025
Actual date on which the first participant was enrolled.This study is exploring a new kind of therapy program for people dealing with serious illnesses. The program uses artificial intelligence to help create a "legacy" document, which is a personal reflection of the patient's life. The goal is to help ease emotional distress and provide comfort by allowing patients to think about and share their life stories with loved ones. This can be especially important for patients who want to leave something meaningful for their family and friends. The study is being conducted at several locations under the Mayo Clinic and is considered to be low risk for participants. Participants in the study will work with a trained facilitator to talk about their life experiences and memories. These conversations are recorded and turned into a written document. The facilitator helps the patient review and edit the document to ensure it accurately reflects their thoughts and feelings. The final "legacy" document is then given to the patient to keep and share with their loved ones. This process is designed to be safe and supportive, providing emotional benefits to the participants by helping them create a tangible legacy.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.40 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Supportive Care Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Criteria
Participant population: Adults with serious illness - defined as a health condition that carries a high risk of mortality Inclusion Criteria for patients: 1. Age ≥18 years 2. English fluency 3. Provide informed consent 4. Ability to complete questionnaire(s) by themselves or with assistance Exclusion Criteria: 1. Other psychological co-morbidities such as untreated schizophrenia, bipolar disease 2. Recent suicide attempt or psychiatric illness severe enough that hospitalization has been necessary in last 6 months 3. Active delirium 4. Advanced dementia 5. Participation in concurrent legacy offerings through the palliative care clinic
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalStudy Objectives
Primary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 2 locations
Mayo Clinic
Rochester, United States